Foresite Capital Management IV
WEST HOLLYWOOD, CAfiles as Foresite Capital Management IV, LLC
$290m in 6 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 12.9% of the portfolio this quarter.
Value
$290m
Stocks
6
Top 10 share
100.0%
Turnover
12.9%
What changed this quarter
New
Bought for the first time this quarter.
- Crinetics PharmaceuticalsCRNX1.9% of the fund
Added
Bought more of a stock they already held.
- CytokineticsCYTK21.0% of the fund+42%
- Relay TherapeuticsRLAY8.1% of the fund+25%
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
- Lyell ImmunopharmaLYEL-100%
- AlectorALEC-100%
- Maze TherapeuticsMAZE-100%
Holdings
- Crinetics PharmaceuticalsCRNX
- Share
- 1.9%
- Value
- $6m
- Shares
- 150,000
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| PharvarisPHVS | 57.0% | $165m | 4,778,581 | Held |
| CytokineticsCYTK | 21.0% | $61m | 714,695 | +42% |
| Eikon TherapeuticsEIKN | 8.7% | $25m | 1,943,682 | Held |
| Relay TherapeuticsRLAY | 8.1% | $23m | 1,250,000 | +25% |
| Xenon PharmaceuticalsXENE | 3.3% | $10m | 160,000 | Held |
| Crinetics PharmaceuticalsCRNX | 1.9% | $6m | 150,000 | New |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 134.4% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.